Translate
About
Endonovo Therapeutics Inc (PINK:ENDV) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 4 2023
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
Oct 12 2023
Endonovo's SofPulse® Secures Taiwan FDA Approval
Aug 22 2023
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Aug 8 2023
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
Jun 22 2023
New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.
Financials
Revenue
$255.72 K
Market Cap
$144.57 K
P/E Ratio
0.00
EPS
0.00